Mitchells & Butlers full year profits drop on Brexit-driven inflationary cost pressures
Rathbone Brothers plc Boosts Position in Gilead Sciences, Inc. (NASDAQ:GILD)
Vanguard S&P 500 Value ETF (VOOV) Rises 0.17% for Nov 24
Today's Brokerage Rating: Rowan Companies plc (RDC), Western Digital Corporation (WDC)
Express Scripts Holding Company (ESRX) Position Lowered by ING Groep NV
Clorox Company (The) (NYSE:CLX) Position Raised by WASHINGTON TRUST Co
14 November 2017, 09:05 | Hattie Nash
Franklin Street Advisors Inc decreased its stake in Clorox Company (CLX) by 19.5% based on its latest 2017Q2 regulatory filing with the SEC. The volume of 0.51 Million shares climbed down over an trading activity of 371.61 Million shares. The Spruce House Investment Management Llc holds 2.80M shares with $148.26 million value, up from 2.08M last quarter.
Other large investors have also bought and sold shares of the company. Shell Asset Management Co. grew its position in shares of Clorox Company (The) by 102.5% during the 3rd quarter. Valley National Advisers Inc. now owns 865 shares of the company's stock worth $115,000 after acquiring an additional 5 shares during the last quarter. Outstanding shares denotes a company's stock now held by all its shareholders, comprising share blocks apprehended by institutional investors and limited shares owned by the officers and insiders of the organization. Blue Chip Partners Inc. boosted its stake in Clorox Company (The) by 3.9% during the second quarter.
In other news, COO Dawn C. Willoughby sold 2,158 shares of the firm's stock in a transaction dated Tuesday, August 29th. Following the completion of the sale, the executive vice president now directly owns 22,069 shares of the company's stock, valued at approximately $3,056,777.19. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The shares were sold at an average price of $138.87, for a total value of $1,280,798.01. The Price to Sales (P/S) of the stock is 2.89, while P/B (Price to Book) stands at 29.43. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 41,293 shares of company stock worth $5,560,303.
The Clorox Company (CLX) ended its previous trading session at $135.08 with the Gain of 2.29%. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US and worldwide copyright and trademark law. The original version of this story can be read at https://stocknewstimes.com/2017/11/14/clorox-company-the-clx-shares-bought-by-first-national-trust-co.html.
Among 14 analysts covering The Clorox Company (NYSE:CLX), 2 have Buy rating, 2 Sell and 10 Hold. The value of the total investment in Clorox Company increased from $37,047,000 to $99,836,000 a change of $62,789,000 for the reporting period. Morgan Stanley has "Equal-Weight" rating and $128 target. Deutsche Bank AG restated a "hold" rating and set a $137.00 price objective (up from $126.00) on shares of Clorox Company (The) in a research report on Saturday, July 22nd. The stock now has a consensus rating of "Hold" and an average target price of $128.72. The same analysts are predicting that the company shares will trade to $133.23 within the next 12-18 months.
The company's ATR (Average True Range) is 0.89. The firm has a market cap of $17,026.34, a price-to-earnings ratio of 23.79, a price-to-earnings-growth ratio of 3.60 and a beta of 0.39. The Clorox Company was covered by a number of analysts recently, 1 rated the stock as Buy, 1 rated Outperform, 12 rated Hold, 1 gave an Underperform and 0 rated sell.
Karni Sena activists vandalise theatre in Rajasthan
Starring Ranveer Singh and Shahid Kapoor along with Deepika in key roles, Padmavati is slated to be released on December 1. On the other side, the director has been claiming that there is no such scene that would hurt anyone's sentiments.
They hope that the stock price will fall or that the company will fail and go bankrupt, leading the equity holders to ruin.
COPYRIGHT VIOLATION WARNING: "Csenge Advisory Group Invests $525,000 in Clorox Company (The) (NYSE:CLX) Stock" was originally reported by TrueBlueTribune and is owned by of TrueBlueTribune. The outstanding shares for The Clorox Company is 129.02, along with a floating outstanding shares of 128.84. The company had revenue of $1.50 billion for the quarter, compared to analyst estimates of $1.48 billion. Clorox Company (The) had a return on equity of 161.59% and a net margin of 11.84%. The company's revenue for the quarter was up 4.0% on a year-over-year basis. analysts expect that Clorox Company will post 5.58 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Monday, November 14th. The short sellers then promise to replace the stock in the future and makes dividend payments out of their own pockets to cover the dividend income that is no longer exists on the original, now borrowed and sold, shares. The firm earned "Underperform" rating on Tuesday, October 4 by Credit Suisse. This represents a $3.36 annualized dividend and a dividend yield of 2.49%. Clorox's dividend payout ratio (DPR) is now 64.91%.
As per Tuesday, September 5, the company rating was maintained by RBC Capital Markets. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors.